Sebastian Gaus is qualified as specialist in psychiatry and psychotherapy. He studied medicine at Charité university hospital from 2007 till 2013 and did his psychiatric and neurological residency at Vivantes Auguste Viktoria hospital. He finished his doctorate at Charité in 2020. His research was about finding biological prediction markers for patients with treatment resistant depression treated with Lithium as augmentation. As a psychotherapist Sebastian is trained in psychodynamic therapy and has a training in couples therapy as well as CBASP for chronically depressed patients. His clinical and research interest lies in the field of affective disorders, specifically chronic and treatment-resistant depression. Sebastian is a study therapist in a randomized-controlled trial investigating psilocybin for treatment-resistant depression in Germany.